Latest Period
Q2 2026
Security Snapshot
Satellos Bioscience Inc. - Common Shares (MSLE) Institutional Ownership
CUSIP: 80401L803
13F Institutional Holders and Ownership History from Q1 2026 to Q2 2026
Institutions Reporting
26
Shares (Excl. Options)
7,684,492
Price
$7.78
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- MSLE on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 7,684,492
- Total 13F value
- $59,579,455
- Portfolio coverage rank
- 0%
- Share change
- +87,426
- Value change
- +$782,838
- Number of holders
- 26
- Shares outstanding
- 15,420,422
- SEC-reported price per share
- $9.82
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MSLE - Satellos Bioscience Inc. - Common Shares is tracked under CUSIP 80401L803.
- 26 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 31 to 26 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $42,791,195 to $59,579,455.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 26 institutions filings for Q2 2026.
Security key
80401L803
Latest holder period
Q2 2026
13F holders
26
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
MSLE full holder history
Satellos Bioscience Inc. SEC filings
Satellos Bioscience Inc. company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 80401L803:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
MSLE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Qiming U.S. Healthcare Fund III, L.P. | 8.3% | $9,713,658 | 1,725,247 | Qiming U.S. Healthcare Fund III, L.P. | 31 Mar 2026 | |||
| Bloom Brian Matthew | 7.4% | $6,381,048 | 1,133,401 | Brian Matthew Bloom | 06 Feb 2026 |
As of 30 Jun 2026, 26 institutional investors reported holding 7,684,492 shares of Satellos Bioscience Inc. - Common Shares (MSLE). This represents 50% of the company’s total 15,420,422 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
50%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 6.1% | 938,666 | 0% | 0% | $7,227,934 |
| Siren, L.L.C. | 5.8% | 892,074 | 0% | 0.14% | $6,935,875 |
| Vivo Capital, LLC | 5.3% | 813,666 | 0% | 0.58% | $6,326,253 |
| Point72 Asset Management, L.P. | 4.4% | 682,700 | -1.2% | 0.01% | $5,307,993 |
| SPHERA FUNDS MANAGEMENT LTD. | 4.2% | 652,590 | +33% | 0.73% | $5,073,887 |
| Woodline Partners LP | 3.2% | 500,432 | 0% | 0.01% | $3,890,859 |
| Stonepine Capital Management, LLC | 3.2% | 491,624 | +392% | 2.8% | $3,723,291 |
| MONTANOVA CAPITAL, LLC | 3.1% | 475,000 | 0% | 0.08% | $3,693,125 |
| Avidity Partners Management LP | 2.5% | 387,769 | 0% | 0.48% | $3,014,904 |
| Saturn V Capital Management LP | 2.3% | 350,000 | 0% | 0.39% | $2,721,250 |
| Soleus Capital Management, L.P. | 2% | 314,359 | -24% | 0.08% | $2,444,141 |
| 683 Capital Management, LLC | 1.5% | 230,833 | 0% | 0.17% | $1,794,727 |
| ADAR1 Capital Management, LLC | 1.4% | 222,555 | 0% | 0.08% | $1,731,478 |
| AWM Investment Company, Inc. | 1.2% | 180,000 | 0.12% | $1,399,500 | |
| MILLENNIUM MANAGEMENT LLC | 0.99% | 152,768 | -49% | 0% | $1,187,771 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.97% | 150,000 | -61% | 0% | $1,166,250 |
| Empery Asset Management, LP | 0.69% | 107,100 | -53% | 0.96% | $832,703 |
| CITADEL ADVISORS LLC | 0.44% | 67,738 | +59% | 0% | $526,663 |
| MORGAN STANLEY | 0.17% | 25,732 | +21% | 0% | $200,066 |
| China Universal Asset Management Co., Ltd. | 0.13% | 20,000 | +212% | 0.01% | $155,500 |
| ROYAL BANK OF CANADA | 0.1% | 15,863 | -2.4% | 0% | $124,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.08% | 11,907 | 0% | 0% | $92,576 |
| UBS Group AG | 0.01% | 781 | +2689% | 0% | $6,073 |
| JPMORGAN CHASE & CO | 0% | 315 | 0% | $2,485 | |
| Federation des caisses Desjardins du Quebec | 0% | 19 | 0% | 0% | $143 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
Q2 2026
Rows shown
1-2 of 2